Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTeclistamab/Talquetamab Appears Tolerable in R/R Multiple Myeloma.SubjectsTHERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents; MEETINGS; MYELODYSPLASTIC syndromes; DRUG tolerance; LYMPHOBLASTIC leukemia; B cell lymphoma; SURVIVAL analysis (Biometry); MULTIPLE myeloma; AMERICAN Society of Clinical Oncology; RECOMBINANT proteins; BREAST tumorsPublicationOncology (08909091), 2023, Vol 37, Issue 8, p343ISSN0890-9091Publication typeArticle